<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1476">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04455308</url>
  </required_header>
  <id_info>
    <org_study_id>35RC20_8888_ECCES</org_study_id>
    <nct_id>NCT04455308</nct_id>
  </id_info>
  <brief_title>COVID-19 and Chilblains</brief_title>
  <acronym>ECCES</acronym>
  <official_title>Chilblains, COVID-19 and Lockdown: Epidemiologic Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chilblains (inflammatory lesion of the feet or hands) have been reported with an unusual
      frequency during the confinement period, most commonly in children, teenagers and young
      adults. The aim of the ECCES study is to find out whether these manifestations of chilblains
      can be linked to the SARS-CoV-2 coronavirus.

      For this, an epidemiologic study will compare two types of family (or more precisely people
      who were confined together in March-April-May):

        -  &quot;case family&quot; in which at least one of the members had chilblains

        -  &quot;comparator family&quot; in which none of the members had chilblains Environment (home
           lockdown) of the two types of family will be analyzed. Each member of the &quot;family&quot; will
           be suggested doing a serological test.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 21, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Level of viral exposure in &quot;case family&quot; compared to &quot;comparator family&quot;</measure>
    <time_frame>Through study completion, an average of 3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of seropositivity rates in subjects with chilblains and their age-matched controls</measure>
    <time_frame>Through study completion, an average of 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of SARS-CoV-2 seropositivity rates among members of case (subject with chilblains) and control (subject without chilblains) outbreaks</measure>
    <time_frame>Through study completion, an average of 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antibody avidity and differentiated IgG and IgM assay by subject in the homes</measure>
    <time_frame>Through study completion, an average of 3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Chilblains</condition>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Subjects with chilblains</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Subjects without chilblains</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Biological sample collection</intervention_name>
    <description>10mL blood sample</description>
    <arm_group_label>Subjects with chilblains</arm_group_label>
    <arm_group_label>Subjects without chilblains</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &quot;case family&quot;

          -  at least one of the members with chilblains

          -  diagnosis of chilblains (anamnesis and pictures) written informed consent

          -  &quot;comparator family&quot;

          -  none of the members with chilblains

          -  one member matched on age (+/- 1 year) to a patient with chilblains

          -  written informed consent

        Exclusion Criteria:

        - Subject legally protected (under judicial protection, guardianship), persons deprived of
        liberty
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alain DUPUY, MD, PhD</last_name>
    <phone>02 99 28 92 34</phone>
    <email>alain.dupuy@chu-rennes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yannick Le Corre, MD</last_name>
      <email>YaLeCorre@chu-angers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emilie BRENAUT, MD</last_name>
      <email>emilie.brenaut@chu-brest.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>SÃ©bastien BARBAROT, MD, PhD</last_name>
      <email>sebastien.barbarot@chu-nantes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain DUPUY, MD, PhD</last_name>
      <phone>02 99 28 92 34</phone>
      <email>alain.dupuy@chu-rennes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU Tours</name>
      <address>
        <city>Tours</city>
        <zip>37170</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mahtab SAMIMI, MD, PhD</last_name>
      <email>mahtab.samimi@univ-tours.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 30, 2020</study_first_submitted>
  <study_first_submitted_qc>July 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2020</study_first_posted>
  <last_update_submitted>July 21, 2020</last_update_submitted>
  <last_update_submitted_qc>July 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chilblains</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

